Publications (184) Victoria Catalán Goñi publications

filter_list

2026

  1. One anastomosis mini-gastric bypass decreases desacyl ghrelin and improves metabolic profile in male rats with diet-induced obesity

    Journal of Nutritional Biochemistry, Vol. 147

2025

  1. Changes in ghrelin isoforms after sleeve gastrectomy or gastric plication and their association with adiposity and metabolic profile

    European Journal of Clinical Investigation, Vol. 55, Núm. 7

  2. Different association of GDF15 and FGF21 with glycemic status and aging in the context of obesity

    GeroScience

  3. Differential effects of bariatric surgery on circulating GDF15 and FGF21 levels: Implications for glycemic status and weight loss outcomes

    European Journal of Clinical Investigation, Vol. 55, Núm. 10

  4. Editorial Commentary: Medical versus surgically-induced weight loss differences on cardiovascular outcomes

    Trends in Cardiovascular Medicine

  5. Increased IL- 36γ in visceral adipose tissue as a key mediator of obesity-driven inflammation in colon cancer

    Journal of Molecular Medicine, Vol. 103, Núm. 6, pp. 699-711

  6. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry, Vol. 81, Núm. 2, pp. 471-482

  7. Oral semaglutide in HFpEF: Real-world evidence and causal considerations

    European Journal of Internal Medicine

  8. Sex- and depot-dependent differences in adipocyte morphology and gene expression in diet-induced obesity

    Diabetes Research and Clinical Practice, Vol. 230

  9. The evolution of the understanding of obesity over the last 100 years: Clinical Research

    International Journal of Obesity, Vol. 49, Núm. 2, pp. 168-176

2024

  1. Cardiometabolic risk stratification using a novel obesity phenotyping system based on body adiposity and waist circumference

    European Journal of Internal Medicine, Vol. 124, pp. 54-60

  2. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  3. Differential mitochondrial adaptation and FNDC5 production in brown and white adipose tissue in response to cold and obesity

    Obesity, Vol. 32, Núm. 11, pp. 2120-2134

  4. FNDC4 reduces hepatocyte inflammatory cell death via AMPKα in metabolic dysfunction-associated steatotic liver disease

    Clinical Nutrition, Vol. 43, Núm. 9, pp. 2221-2233

  5. Increased expression levels of PIEZO1 in visceral adipose tissue in obesity and type 2 diabetes are triggered by mechanical forces and are associated with inflammation

    Molecular Medicine, Vol. 30, Núm. 1

  6. Single anastomosis duodeno-ileal bypass with sleeve gastrectomy generates sustained improvement of glycemic control compared with sleeve gastrectomy in the diet-induced obese rat model

    Journal of Physiology and Biochemistry, Vol. 80, Núm. 1, pp. 149-160

  7. Will the manipulation of the gut microbiota be effective for the treatment of metabolic diseases?

    European Journal of Internal Medicine

2023

  1. Antagonic effect of ghrelin and LEAP-2 on hepatic stellate cell activation and liver fibrosis in obesity-associated nonalcoholic fatty liver disease

    European journal of endocrinology, Vol. 188, Núm. 7, pp. 564-577

  2. BMI-based obesity classification misses children and adolescents with raised cardiometabolic risk due to increased adiposity

    Cardiovascular Diabetology, Vol. 22, Núm. 1

  3. Corrigendum: Increased levels of interleukin-36 in obesity and type 2 diabetes fuels adipose tissue inflammation by inducing its own expression and release by adipocytes and macrophages(Front. Immunol., (2022), 13, (832185), 10.3389/fimmu.2022.832185)

    Frontiers in Immunology